Please select one of the options below:


Enroll a Patient
Patient Lookup


65219-371-10 Stimufend® (pegfilgrastim-fpgk) 6 mg/0.6 mL Pre-filled Syringe

Patient enrollment offers copay assistance for all of the following medications

Product Name Strength/Concentration NDC
Arsenic Trioxide 10mg per 10mL 63323-637-10
63323-637-03
Bleomycin 15 units per vial 63323-136-10
30 units per vial 63323-137-20
Cladribine 10mg per 10mL 63323-140-10
Clofarabine 20mg per 20mL 63323-572-70
Cytarabine 2g per 20mL 63323-120-20
Etoposide 100mg per 5mL 63323-104-05
63323-104-01
500mg per 25mL 63323-104-25
1g per 50mL 63323-104-50
Fludarabine Phosphate 50mg per 2mL 63323-192-02
Product Name Strength/Concentration NDC
Fulvestrant 250mg per 5mL 63323-715-01
63323-715-05
Leucovorin Calcium 100mg per 10mL 63323-631-10
200mg per vial 63323-710-50
500mg per 50mL 63323-631-50
500mg per vial 63323-711-00
Melphalan HCL 50mg per vial 63323-760-20
Mesna 1g per 10mL 63323-733-11
63323-733-01
Methotrexate 250mg per 10mL 63323-123-10
1g per vial 63323-122-50
Product Name Strength/Concentration NDC
Mitoxantrone Inj, USP 20mg per 10mL 63323-132-10
25mg per 12.5mL 63323-132-12
Octreotide Acetate 100mcg per 1mL 63323-376-01
500mcg per 1mL 63323-377-01
1mg per 5mL 63323-378-05
5mg per 5mL 63323-379-05
Romidepsin 10mg per vial 63323-926-88
Temsirolimus 25mg per mL 65219-200-05
Topotecan HCl 4mg per vial 63323-762-10
VinBLAStine Sulfate 10mg per 10mL 63323-278-10
Zoledronic Acid 5mg per 100mL 63323-966-00

TERMS AND CONDITIONS

To receive benefits under the Copay Assistance Program, the patient may contact the KabiCare Patient Support Program for current Program Product(s) subject to these Terms and Conditions. By participating in the Copay Assistance Program, patient acknowledges and agrees that he/she is eligible to participate and that he/she understands and agrees to comply with these Terms and Conditions.


  • Patient must be prescribed the Program Product for an FDA-approved indication.
  • Patient must have commercial (private or non-governmental) health insurance that provides coverage for the cost of the Program Product under a pharmacy or medical benefit plan.
  • The Copay Assistance Program is valid for patients who have a valid prescription for a Fresenius Kabi medication and who are not reimbursed for the entire cost of the prescription by their commercial insurance plan. The Copay Assistance Program is not valid for patients enrolled in Medicaid, Medicare (including a Medicare Part D or Medicare Advantage plan, a Medigap plan, or an employer-sponsored health plan or prescription drug benefit program for Medicare-eligible retirees), Veteran Affairs health care programs, Department of Defense health care programs, TRICARE, CHAMPUS, Puerto Rico Government Health Insurance Plan , or any other state or federal medical or pharmaceutical benefit program or pharmaceutical assistance program, including any state pharmaceutical assistance programs (collectively, "Government Programs"). Patients who move from commercial insurance to Government Programs will no longer be eligible to participate in the Copay Assistance Program and agree to notify the Copay Assistance Program of any such change. If the patient lives in Massachusetts, the Copay Assistance Program expires on the earlier of: (i) the Expiration Date set forth below; (ii) the date an AB-rated generic equivalent becomes available for the Program Product; or (iii) January 31, 2026, absent a change in Massachusetts state law.
    If the patient lives in California, the Copay Assistance Program expires on the earlier of: (i) the Expiration Date set forth below; or (ii) the date an FDA approved therapeutically equivalent for the Program Product or over the counter product with the same active ingredients becomes available.
  • Patients must have an out-of-pocket cost for the Program Product prior to the Expiration Date of the Copay Assistance Program set forth below.
  • The benefit available under the Copay Assistance Program is limited to the amount the patient's private health insurance company indicates that the patient is obligated to pay for up to a per syringe/annual maximum.
  • The Program may apply to patient out-of-pocket costs incurred for Program Product subject to per syringe/annual maximums based on Program Product administration date. The maximum Copay Assistance Program benefit is no more than $5,000 per syringe and $15,000.00 per calendar year (January 1 through December 31). After reaching the maximum Copay Assistance Program benefit, the patient will be responsible for all remaining out-of-pocket expenses. The patient or provider may contact the KabiCare Patient Support Program for more information.
  • This Copay Assistance Program benefit is for commercially insured patients only. Uninsured and cash paying patients may be eligible for other types of support not part of the Copay Assistance Program.
  • The Patient and participating pharmacy or healthcare professional agree not to seek reimbursement for all, or any part, of the benefit received by the patient through the Copay Assistance Program. Participating patients and pharmacies or health care professionals are responsible for reporting receipt of Copay Assistance Program benefits as may be required by law.
  • Patient must be a resident of the United States or the Commonwealth of Puerto Rico. Product must originate and be administered to patient in the United States or the Commonwealth of Puerto Rico.
  • All information applicable to the Copay Assistance Program requested on the KabiCare.US site must be provided, and all certifications must be provided. No other purchase is necessary.
  • The Copay Assistance Program is not insurance.
  • It is illegal to sell, purchase, trade, counterfeit, or duplicate, or offer to sell, purchase, trade counterfeit, or duplicate the Copay Assistance Program card. Void if reproduced.
  • The Copay Assistance Program is intended to comply with all applicable laws and regulations, including, without limitation, the federal Anti-Kickback Statute, its implementing regulations, and related guidance interpreting the federal Anti-Kickback Statute.
  • The Copay Assistance Program is void where prohibited by law, taxed, or restricted. The Copay Assistance Program is not transferable. No substitutions are permitted.
  • The Copay Assistance Program benefit has no cash value and cannot be combined with any other Copay Assistance Program, free trial, discount, rebate, prescription savings card, or other offer.
  • The full value of the Copay Assistance Program benefit is intended to pass entirely to the patient. No other individual or entity is entitled to receive any discount or other amount in connection with the Copay Assistance Program.
  • This offer is not conditioned on any past, present, or future purchase obligation, and the Copay Assistance Program does not obligate the use of any specific product or provider.
  • To the extent applicable, this offer will be accepted only at participating pharmacies, to the extent applicable.
  • KabiCare reserves the right to rescind, revoke, terminate, or amend the Copay Assistance Program at any time without notice.
  • Data related to patient's receipt of Copay Assistance Program benefits may be collected, analyzed, and shared with KabiCare, for market research and other purposes related to assessing Copay Assistance Programs. Data shared with KabiCare will be aggregated and de-identified, meaning it will be combined with data related to other Copay Assistance Program redemptions and will not identify patient.
  • The Terms and Conditions of the Copay Assistance Program are valid for Program Product only, and Fresenius Kabi reserves the right to rescind, revoke, or amend the Program without notice.
Expand Terms and Conditions